Reliability and Validity of the Turkish Version of the Coping Strategies Questionnaire

March 25, 2019 updated by: Ugur Sozlu, Gazi University

Coping Strategies Questionnaire: Translation, Cultural Adaptation, Reliability and Validity in Turkish-Speaking Subjects With Chronic Musculoskeletal Pain

Chronic musculoskeletal pain is a major health problem in 35% of the general population in most developed countries. In addition to interventional therapies, the cognitive and behavioral abilities of the patient, are important for the solution of chronic pain. All of these abilities of patients are called coping strategies of pain.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The Coping Strategies Questionnaire (CSQ) is commonly used to measure methods of coping with various forms of chronic pain, including musculoskeletal pain. CSQ aims to evaluate the frequency and success of coping strategies with cognitive and behavioral pain. The validity and reliability of the questionnaire was tested and satisfactory results were obtained and it became a widely used tool in pain studies. The aim of this study was to translate and culturally adapt the original English version of the CSQ into Turkish version and to assess the validity and reliability of this instrument in patients with chronic musculoskeletal pain.

Study Type

Observational

Enrollment (Actual)

123

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Yenimahalle
      • Ankara, Yenimahalle, Turkey, 06500
        • Gazi University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with chronic musculoskeletal pain.

Description

Inclusion Criteria:

  • Being eighteen years old or older,
  • being diagnosed with chronic musculoskeletal pain (at least 6 months),
  • Being a native Turkish speaker and being able to read Turkish,
  • Receiving no treatment between test-retest assessments.

Exclusion Criteria:

  • Inability to complete the form due to significant psychiatric or psychological disorder,
  • having a neurological disease,
  • Pregnant women.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reliability of Coping Strategies Questionnaire (CSQ)
Time Frame: 1 year

As a result of the internal consistency analysis, Cronbach's Alpha coefficient was found to be 0.913. This value indicates that the scale has a high level of internal consistency.

For the test-retest analysis of the Turkish version (CSQ-T), a 48-hour time interval was considered to be appropriate, and 40 participants were included in the test. As a result of the analysis, the ICC value was computed for the total score of the scale, which was found to be fairly high (0.876). The results revealed that both the sub-parameters and the total score of the CSQ, and thus the CSQ itself are stable over time.

Based on these findings, the Turkish version of the questionnaire appears to have high reliability.
1 year
Validity of Coping Strategies Questionnaire (CSQ)
Time Frame: 1 year

Construct validity was measured by comparing the responses of the scales of the CSQ-T with the responses of the scales of the HADS and SF-36. The total CSQ-T correlated to the anxiety subscale of the HADS with a score of r:-0.603 and to the depression subscale of the HADS with scores of r:-0.471. The SF-36 "PCS" (r: 0.790) and "MCS" (r:822) subscales were observed to have a good and very good correlation with the total score of CSQ-T.

Based on these findings, the Turkish version of the questionnaire appears to have high validity.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Gazi University

Investigators

  • Study Chair: Selda BAŞAR, Gazi University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 15, 2017

Primary Completion (Actual)

September 14, 2018

Study Completion (Actual)

September 20, 2018

Study Registration Dates

First Submitted

March 21, 2019

First Submitted That Met QC Criteria

March 25, 2019

First Posted (Actual)

March 26, 2019

Study Record Updates

Last Update Posted (Actual)

March 26, 2019

Last Update Submitted That Met QC Criteria

March 25, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • E.70271

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Musculoskeletal Pain

Clinical Trials on Questionnaire

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe